Fibank explores strategic options, including new investors

Fibank (5F4 BU), 3rd largest bank in Bulgaria, explores strategic options and hired Citigroup Global Markets Limited as a financial adviser, the Company announced in a regulatory filing. The strategic opportunities include: Entering a strategic partnership and/or consolidation; Attracting new core investors; Raising capital to fund future growth. No time frame for the initiated exploration… Read more





Roadshow: Bulgarian Capital Market Day in London on 18 May 2017

A special Bulgarian Capital Market Day for CEE-focused investors will take place at EBRD headquarters on 18 May 2017 presenting for one day an insight in CEE regional development and Bulgarian capital market in-depth.


Sopharma

New research report: Sopharma finally catches the tailwinds

Sopharma – the leading generic pharmaceutical company in Bulgaria – booked a 2016 performance in line with ELANA Trading analysts’ expectations. Top line negative surprises seem fading away, operating profits sustained on cost optimization and profitable divestments made the bottom line. Sales in line with analysts’ expectations After losing a quarter of its operations due… Read more


A glimpse on audit impact on financial statements FY 2016

Audit ups Speedy’s (0SP BU) unconsolidated net income by 20% to BGN 7.7m, according to the Company’s audited unconsolidated FY2016 financial statements published at the end of March 2017. Audited net income stands at BGN 7.7m, up 20% vs. preliminary announced result of BGN 6.4m. The latter is due mostly on 24% lower depreciation expense… Read more